Buy Minor Cannabinoids in Canada (CBN, CBG, CBC)

Montrose Cannabis is your trusted source for buying the fascinating world of minor cannabinoids in Canada. We are proud to present a diverse collection featuring CBN (cannabinol), CBG (cannabigerol), CBC (cannabichromene), and THCV (tetrahydrocannabivarin) allowing you to experience the full spectrum of cannabis benefits beyond the well-known THC and CBD. We believe in providing a holistic cannabis experience. While THC and CBD take the spotlight, minor cannabinoids play a crucial role in the entourage effect, enhancing the overall therapeutic potential of the plant. Our collection is carefully curated to showcase the unique properties and benefits of CBN, CBG, CBC and THCV. Unlock the potential of minor cannabinoids in Canada with Montrose Cannabis. Lift your cannabis experience, explore new dimensions of wellness, and get on a journey of discovery with CBN, CBG, CBC and THCV. Shop confidently with us, where quality, transparency, and education converge to redefine your cannabis journey.

What Are Minor Cannabinoids?

In the realm of cannabis, the spotlight often falls on two major cannabinoids, THC (tetrahydrocannabinol) and CBD (cannabidiol). However, the cannabis plant boasts a diverse array of compounds, including lesser-known players called minor cannabinoids. These compounds, though present in smaller quantities, are gaining increasing attention for their potential therapeutic benefits. In this article, we will delve into the world of minor cannabinoids, shedding light on the hidden gems that contribute to the complex and nuanced effects of the cannabis plant.

While THC and CBD dominate discussions, cannabis produces over 100 different cannabinoids, each with its unique properties. Minor cannabinoids, as the name suggests, are present in smaller concentrations compared to THC and CBD but play crucial roles in the overall therapeutic profile of the plant. Some notable minor cannabinoids include CBG (cannabigerol), CBC (cannabichromene), CBN (cannabinol), and THCV (tetrahydrocannabivarin).

In the ever-evolving landscape of cannabis research, minor cannabinoids are emerging as essential contributors to the plant’s therapeutic potential. As we continue to unravel the complexities of these hidden gems, the future holds exciting possibilities for incorporating minor cannabinoids into innovative wellness and medical solutions. From CBG’s anti-inflammatory properties to CBN’s potential as a sleep aid, the diverse world of minor cannabinoids is a fascinating frontier that promises new insights and breakthroughs in the realm of cannabis-based therapies.


Cannabinol, or CBN, is a minor cannabinoid that results from the degradation of THC. Known for its mildly psychoactive properties, CBN is often associated with relaxation and sleep aid. Some studies suggest potential anti-inflammatory and pain-relieving effects, making it an intriguing compound for those seeking natural remedies for various conditions.


Often referred to as the “stem cell” of cannabinoids, Cannabigerol, or CBG, is the precursor to THC, CBD, and other cannabinoids. While it is present in lower concentrations, CBG has gained attention for its potential anti-inflammatory, antibacterial, and neuroprotective properties. Some research suggests CBG may also aid in managing conditions like glaucoma and inflammatory bowel disease.


Cannabichromene, or CBC, is a non-psychoactive cannabinoid that may contribute to the entourage effect without inducing a high. Preliminary studies suggest potential anti-inflammatory, anti-depressant, and analgesic effects. CBC interacts with both the CB1 and CB2 receptors in the endocannabinoid system, showcasing its versatility in providing therapeutic benefits.


THCV is a unique cannabinoid known for its potential appetite-suppressant properties. While structurally similar to THC, it produces different effects and is found in smaller quantities in the cannabis plant. Some research suggests that THCV may have neuroprotective effects and could be explored for its potential in managing conditions like obesity and diabetes.

The entourage effect is a phenomenon where the combined action of various cannabinoids, terpenes, and other compounds in the cannabis plant creates a synergistic effect that enhances the therapeutic benefits of each component. Minor cannabinoids, in collaboration with THC and CBD, contribute to this entourage effect, making full-spectrum and broad-spectrum cannabis products highly sought after for a more comprehensive wellness experience.

As our understanding of cannabis continues to evolve, so does our appreciation for the potential benefits of minor cannabinoids. From CBN’s calming properties to CBG’s versatile applications, these compounds offer a diverse array of therapeutic possibilities. Researchers and enthusiasts alike are delving deeper into the intricacies of these cannabinoids, unlocking new insights into the holistic potential of the cannabis plant.

While THC and CBD often take the spotlight, the world of minor cannabinoids is a fascinating realm that holds promise for the future of cannabis-based wellness. As scientific research advances, we can anticipate more discoveries that will further illuminate the unique contributions of minor cannabinoids to the complex tapestry of cannabis chemistry.